Elixinol Wellness (ASX:EXL): US Business Sale Reshapes Consumer Wellness Strategy

Sonal Goyal

18 September 2026 06:35 PM AEST

Elixinol Wellness (ASX:EXL): US Business Sale Reshapes Consumer Wellness Strategy

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Elixinol Wellness (ASX:EXL) has shifted towards an Australian-focused consumer wellness model.
The company completed the sale of its US Business to simplify operations.
Remaining brands include Hemp Foods Australia and The Healthy Chef.
Revenue growth, profitability improvement and Cash Management remain key areas to monitor.

Elixinol Wellness Ltd (ASX:EXL) is an Australian consumer wellness company focused on hemp-based foods, nutrition products and health-related consumer brands. Following the sale of its US business, the company is concentrating on its Australian operations and existing product portfolio. This article examines the strategic shift and the factors shaping the company’s next phase.

Reshaping the Business Structure

Elixinol completed the sale of its US business, marking a move away from its previous international CBD-focused operations. The transaction reduced exposure to the challenges associated with the US market and allowed the company to focus on its remaining Australian brands.

The retained business is centred on consumer products rather than regulated medicines, with products distributed through grocery, pharmacy, wholesale and online channels.

Australian Consumer Brands

Elixinol’s ongoing portfolio includes Hemp Foods Australia, The Healthy Chef and hemp ingredient products supplied to food manufacturers.

These brands operate within the consumer wellness market, where product awareness, distribution relationships and customer Demand are important factors influencing performance.

Financial Performance and Operational Focus

The company reported improved performance from continuing operations, supported by growth across selected brands and improved margins. The business has focused on reducing complexity and improving operational efficiency following the US divestment.

A simplified structure allows management to concentrate resources on areas where the company has established capabilities and market presence.

Future Considerations

Elixinol’s next stage depends on building sustainable growth from its Australian consumer brands while maintaining financial discipline. The company operates in competitive food and wellness categories where customer preferences and market conditions continue to evolve.

Key Insights

Elixinol Wellness has transitioned from a broader international CBD-focused model towards a more focused consumer wellness strategy. The company’s future progress will depend on Brand development, operational execution and its ability to generate consistent growth from its retained businesses.

FAQs

Q: What does Elixinol Wellness do?

A:Elixinol develops consumer wellness products including hemp-based foods and nutritional products.

Q: Why did Elixinol sell its US business?

A:The sale allowed the company to simplify operations and focus on its Australian business.

Q: What brands remain part of Elixinol’s portfolio?

A:The company’s brands include Hemp Foods Australia and The Healthy Chef.

Q: What factors may influence Elixinol’s progress?

A:Brand growth, consumer demand and financial management are key factors.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.